We are live on ! Find out more
CALC icon

CalciMedica
CALC

26 hedge funds and large institutions have $37M invested in CalciMedica in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 11 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% less call options, than puts

Call options by funds: $887K | Put options by funds: $1.26M

37% less funds holding

Funds holding: 41 → 26 (-15)

42% less capital invested

Capital invested by funds: $63.7M → $37M (-$26.7M)

78% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 18

82% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 11

Holders
26
Holders Change
-15
Holders Change %
-36.59%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
11
Closed
18
Calls
$887K
Puts
$1.26M
Net Calls
-$372K
Net Calls Change
+$1.15M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$433K
2
BCM
Bridgeway Capital Management
Texas
+$362K
3
Citadel Advisors
Citadel Advisors
Florida
+$328K
4
Northern Trust
Northern Trust
Illinois
+$16.6K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$9.84K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$1.22M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$883K
3
VF
Virtu Financial
New York
-$358K
4
HF
HRT Financial
New York
-$153K
5
Bessemer Group
Bessemer Group
New Jersey
-$146K

CALC Hedge Fund Activity: Q3 2021 in Review

26 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2021, worth a combined $37M — down 42% from $63.7M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CALC and 4 opened new positions — a net loss of 14 holders — while 11 trimmed existing stakes and 2 added.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $433K. The largest seller was Morgan Stanley, cutting an estimated $1.22M.

  • 26 institutional investors held CalciMedica (CALC) as of Q3 2021, down from 41 in Q2 2021.
  • Funds reported $37M of CalciMedica stock for Q3 2021, down 42% quarter-over-quarter.
  • 4 funds opened new CalciMedica positions in Q3 2021 and 18 closed out, a net change of -14 holders.
  • The largest CalciMedica buyer in Q3 2021 was JP Morgan Chase, an estimated $433K added.
  • The largest CalciMedica seller in Q3 2021 was Morgan Stanley, an estimated $1.22M sold.

Based on aggregated 13F filings for Q3 2021.